| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/02/1993 | US5190922 Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands |
| 03/02/1993 | US5190921 Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
| 03/02/1993 | US5190920 Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity |
| 03/02/1993 | US5190918 Peptide fragments and analogs of thrombospondin and methods of use |
| 03/02/1993 | US5190916 Use of ovomacroglobulin as an agent for treating wound and inflammation |
| 03/02/1993 | US5190873 Hybrid tryptophan aporepressor containing ligand binding sites |
| 03/02/1993 | US5190859 Purification of LFA-3 |
| 03/02/1993 | US5190756 Methods and materials for expression of human plasminogen variant |
| 03/02/1993 | CA1314011C Method for the purification of proteins |
| 03/02/1993 | CA1314010C Method to export gene products to the growth medium of gram negative bacteria |
| 03/01/1993 | WO1993005152A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2094242A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2077002A1 Substituted 2,3-diamino acids, processes for their preparation and their use as intermediates for peptide active substances |
| 03/01/1993 | CA2076995A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 02/27/1993 | WO1993004080A1 Pseudopentapeptides with immunomodulating activity |
| 02/27/1993 | CA2094822A1 Pseudopentapeptides with immunomodulating activity |
| 02/27/1993 | CA2076798A1 Kainate-binding, human cns receptors of the eaa1 family |
| 02/27/1993 | CA2076403A1 Assay for evaluating inhibition of pmn elastase by n-substituted azetidinones |
| 02/24/1993 | EP0528716A1 Human hemoglobin derivatives, process for preparing them, products derived therefrom and use of these derivatives and products |
| 02/24/1993 | EP0528686A2 Process for producing peptides |
| 02/24/1993 | EP0528663A2 Monoclonal antibody to a synaptophysin |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528500A2 A method for reduction of central nervous system (CNS) edema resulting from head and spinal cord trauma |
| 02/24/1993 | EP0528487A2 Novel chromophore containing compounds |
| 02/24/1993 | EP0528312A2 Cyclic peptides and use thereof |
| 02/24/1993 | EP0528271A1 Human parathyroid hormone muteins and production thereof |
| 02/24/1993 | EP0528011A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527954A1 Molecular recognition units |
| 02/24/1993 | EP0527916A1 Antisense inhibitors of the human immunodeficiency virus |
| 02/24/1993 | EP0527914A1 Novel synthetic grf analogs |
| 02/24/1993 | EP0527839A1 Recombinant library screening methods |
| 02/24/1993 | EP0527822A1 T-cell suppressor protein |
| 02/24/1993 | EP0527815A1 Hepatitis c virus epitopes |
| 02/24/1993 | EP0527814A1 An immortalized primate hepatocyte cell line. |
| 02/24/1993 | EP0527806A1 Epithelins: novel cysteine - rich growth modulating proteins |
| 02/24/1993 | EP0527804A1 Gene therapy for cell proliferative diseases |
| 02/24/1993 | EP0527802A1 Ligand for the neu gene product. |
| 02/24/1993 | EP0527789A1 Hiv envelope polypeptides |
| 02/24/1993 | EP0527788A1 Hepatitis c virus protease |
| 02/24/1993 | EP0527786A1 Purified hcv and hcv proteins and peptides |
| 02/24/1993 | EP0527785A1 Improvements relating to the detection of viruses |
| 02/24/1993 | EP0527781A1 Methods and formulations for stabilizing fibroblast growth factor |
| 02/24/1993 | EP0527778A1 Improved process of purifying recombinant proteins and compounds useful in such process. |
| 02/24/1993 | EP0527771A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 02/24/1993 | EP0527767A1 Self-polymerising expression system based on modified potyvirus coat proteins |
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527763A1 Method to purify basic fibroblast growth factor |
| 02/24/1993 | EP0527761A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527752A1 Expression of heterologous protein in yeast |
| 02/23/1993 | US5189151 Highly specific DNA probe for enteroaggregative escherichia coli |
| 02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
| 02/23/1993 | US5189147 Meterodimeric T lymphocyte receptor antibody |
| 02/23/1993 | US5189146 Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 02/23/1993 | US5189145 Flower-inducing substances and a method for production thereof |
| 02/23/1993 | US5189144 Human calpastatin-like polypeptide |
| 02/23/1993 | US5189022 Using polypeptide |
| 02/23/1993 | US5189020 Method of reducing neuronal damage using omega conotoxin peptides |
| 02/23/1993 | US5189019 Antistasin derived anticoagulant protein |
| 02/23/1993 | US5189018 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/23/1993 | US5189015 Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability |
| 02/23/1993 | US5189014 Administering a dose of one Fc reagent selected from exogenous polypeptide having atleast one site binds to the Fc-portion of said antigen-antibody immune complex being susceptible to such binding; immunotherapy |
| 02/23/1993 | US5188969 Monoclonal antibody to human lymphotoxin and use thereof |
| 02/23/1993 | US5188967 Contacting sample tissue or serum from human with a reagent recognizing gene coding for human villin |
| 02/23/1993 | US5188964 Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination |
| 02/23/1993 | US5188960 Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 02/23/1993 | US5188957 Lambda packaging extract lacking beta-galactosidase activity |
| 02/23/1993 | US5188954 High-affinity human serotonin uptake system |
| 02/23/1993 | US5188943 Method of producing high molecular weight human fibroblast growth factors |
| 02/23/1993 | US5188933 Dna sequences coding protein having immunosuppressant activity |
| 02/23/1993 | CA1313831C Method of generating desired aminoterminal residues in proteins and methods of regulating metabolic stability of proteins |
| 02/23/1993 | CA1313818C Nuclear antigen la |
| 02/20/1993 | CA2076321A1 Method for reduction of central nervous system (cns) edema resulting from head and spinal cord trauma |
| 02/18/1993 | WO1993003376A1 Immunoassay for the simultaneous detection of hiv-1, hiv-2, htlv-i and htlv-ii antibodies |
| 02/18/1993 | WO1993003375A1 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 02/18/1993 | WO1993003371A1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
| 02/18/1993 | WO1993003370A1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 02/18/1993 | WO1993003179A1 Device for detecting aqueous contaminants |
| 02/18/1993 | WO1993003174A1 Tissue-selective insulin analogs |
| 02/18/1993 | WO1993003173A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
| 02/18/1993 | WO1993003172A1 Systematic polypeptide evolution by reverse translation |
| 02/18/1993 | WO1993003167A1 Method of isolation of dna |
| 02/18/1993 | WO1993003164A1 Transgenic protein production |
| 02/18/1993 | WO1993003163A1 Expression in non-tumoral human lymphoblastoid lines with an integrative vector |
| 02/18/1993 | WO1993003162A1 Ecdysteroid dependent regulation of genes in mammalian cells |
| 02/18/1993 | WO1993003161A1 Recombinant plant viral nucleic acids |
| 02/18/1993 | WO1993003160A1 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 02/18/1993 | WO1993003159A1 Highly stable recombinant yeasts for the production of recombinant proteins |
| 02/18/1993 | WO1993003158A1 System for protein expression and secretion especially in corynebacteria |
| 02/18/1993 | WO1993003157A1 Plasmids for the rapid preparation of modified proteins |
| 02/18/1993 | WO1993003156A1 Sequence for stabilizing proteins in bacteria protein stabilization sequence |
| 02/18/1993 | WO1993003154A1 Novel microorganism and insecticide |
| 02/18/1993 | WO1993003153A1 Nucleotide sequences coding for ribosome inactivating proteins |
| 02/18/1993 | WO1993003152A1 Igf-ii analogues |
| 02/18/1993 | WO1993003151A1 Treatment of cell populations |
| 02/18/1993 | WO1993003145A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/18/1993 | WO1993003144A1 Viral vector-based insecticides and expression systems |
| 02/18/1993 | WO1993003143A1 Retroviral vectors containing internal ribosome entry sites |
| 02/18/1993 | WO1993003138A1 A method for over-expressing nucleic acids using an enhancer sequence from potato virus x |
| 02/18/1993 | WO1993003137A1 Human substance p receptor |